EDAP TMS S.A. (EDAP)

Market Cap	298.20M
Revenue (ttm)	53.22M
Net Income (ttm)	2.67M
Shares Out	36.15M
EPS (ttm)	0.06
PE Ratio	137.50
Forward PE	38.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,583
Open	8.05
Previous Close	8.12
Day's Range	8.05 - 8.37
52-Week Range	5.00 - 8.99
Beta	1.25
Analysts	Buy
Price Target	11.56 (+40.1%)
Earnings Date	Nov 15, 2022

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological an...

• Industry: Health Care Equipment & Supplies
• IPO Date: Jul 31, 1997
• Employees: 227
• Stock Exchange: NASDAQ
• Ticker Symbol: EDAP

Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for EDAP stock is "Buy." The 12-month stock price forecast is 11.56, which is an increase of 40.12% from the latest price.

Price Target

$11.56

(40.12% upside)

Analyst Consensus: Buy

Stock Forecasts